Company / Operating Income per Share
Outlook Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.00
FY2025
5-year range
-$3.28 / -$1.27
FY2021-FY2025
Trend
-136.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 6 years, ranging from $-4.93 in FY2016 to $-1.27 in FY2020.
Based on SEC 10-K filings.
-3.00 in FY2025.
Improved from $-3.28 to $-3.00 over the past 6 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 136.4% year-over-year.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.00 | -136.4% |
| FY2020 | -$1.27 | +61.4% |
| FY2019 | -$3.28 | -128.2% |
| FY2018 | -$1.44 | +36.1% |
| FY2017 | -$2.25 | +54.4% |
| FY2016 | -$4.93 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026